These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26655727)

  • 1. Artificial polyepitope HIV-1 immunogen containing mimotope of 2F5 epitope.
    Shcherbakova NS; Shcherbakov DN; Bakulina AY; Karpenko LI; Ryzhikov AB; Ilyichev AA
    Protein Pept Lett; 2016; 23(2):159-68. PubMed ID: 26655727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.
    Karpenko LI; Scherbakova NS; Chikaev AN; Tumanova OY; Lebedev LR; Shalamova LA; Pyankova OG; Ryzhikov AB; Ilyichev AA
    Mol Immunol; 2012 Apr; 50(4):193-9. PubMed ID: 22341130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Artificial Immunogens Containing Peptide Mimotopes of HIV-1 Epitopes Recognized by Monoclonal Antibodies 2F5 and 2G12.
    Shcherbakova NS; Chikaev AN; Rudometov AP; Shcherbakov DN; Il'ichev AA; Karpenko LI
    Bull Exp Biol Med; 2019 Jun; 167(2):259-262. PubMed ID: 31243678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope.
    Rudometov AP; Chikaev AN; Rudometova NB; Antonets DV; Lomzov AA; Kaplina ON; Ilyichev AA; Karpenko LI
    Vaccines (Basel); 2019 Aug; 7(3):. PubMed ID: 31390770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein.
    Liang X; Munshi S; Shendure J; Mark G; Davies ME; Freed DC; Montefiori DC; Shiver JW
    Vaccine; 1999 Jul; 17(22):2862-72. PubMed ID: 10438057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
    Ringel O; Müller K; Koch J; Brill B; Wolf T; Stephan C; Vieillard V; Debré P; Dietrich U
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):365-374. PubMed ID: 29262692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELNKWA-epitope specific antibodies induced by epitope-vaccine recognize ELDKWA- and other two neutralizing-resistant mutated epitopes on HIV-1 gp41.
    Dong XN; Xiao Y; Chen YH
    Immunol Lett; 2001 Jan; 75(2):149-52. PubMed ID: 11137140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
    Matyas GR; Wieczorek L; Beck Z; Ochsenbauer-Jambor C; Kappes JC; Michael NL; Polonis VR; Alving CR
    AIDS; 2009 Oct; 23(16):2069-77. PubMed ID: 19710597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
    Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime.
    Yu Y; Tong P; Li Y; Lu Z; Chen Y
    Sci China Life Sci; 2014 Jan; 57(1):117-27. PubMed ID: 24369352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of biotinylation on the ability of a computer designed protein to detect B-cells producing anti-HIV-1 2F5 antibodies.
    Coêlho DF; Ferraz MVF; Marques ETA; Lins RD; Viana IFT
    J Mol Graph Model; 2019 Dec; 93():107442. PubMed ID: 31479948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.
    Eckhart L; Raffelsberger W; Ferko B; Klima A; Purtscher M; Katinger H; Rüker F
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2001-8. PubMed ID: 8810996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
    Virology; 2017 May; 505():113-126. PubMed ID: 28237764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constrained peptide models from phage display libraries highlighting the cognate epitope-specific potential of the anti-HIV-1 mAb 2F5.
    Palacios-Rodríguez Y; Gazarian T; Huerta L; Gazarian K
    Immunol Lett; 2011 Apr; 136(1):80-9. PubMed ID: 21237206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of high levels of antibodies recognizing the neutralizing epitope ELDKWA and the D- or K-position-mutated epitopes by candidate epitope vaccines against HIV-1.
    Xiao Y; Dong X; Chen Y
    Int Arch Allergy Immunol; 2000 Aug; 122(4):287-92. PubMed ID: 10971120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine.
    Wahome N; Pfeiffer T; Ambiel I; Yang Y; Keppler OT; Bosch V; Burkhard P
    Chem Biol Drug Des; 2012 Sep; 80(3):349-57. PubMed ID: 22650354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of high level of specific antibody response to the neutralizing epitope ELDKWA on HIV-1 gp41 by peptide-vaccine.
    Liao M; Lu Y; Xiao Y; Dierich MP; Chen Y
    Peptides; 2000 Apr; 21(4):463-8. PubMed ID: 10822100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.
    Chikaev AN; Bakulina AY; Burdick RC; Karpenko LI; Pathak VK; Ilyichev AA
    PLoS One; 2015; 10(3):e0120847. PubMed ID: 25785734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs.
    Zhang L; Miao L; Gong X; Zhang H; Yang L; Shi Y; Kong W; Jiang C; Shan Y
    J Pept Sci; 2013 Aug; 19(8):491-8. PubMed ID: 23794478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.